Sagent Pharma Stock Price (NASDAQ:SGNT)

Add to My Stocks
$21.76 $0.03 (0.14%) SGNT stock closing price Aug 29, 2016 (Closing)
Prev Close* : $21.73
Market Cap:
$716.12M
Day Low: $21.74
52 Week Low: $10.55
Open: $21.74
Volume: -
Day High: $21.76
52 Week High: $21.88
Dividend:
0.00

Latest Stock Market News

Latest Articles

Sagent Pharma News - From Partners

SGNT Stockcharts

View SGNT PE ratio, PS ratio stocks charts and compare with peers.
SGNT Chart
Note: Compare Sagent Pharma stock price history with the index and industry peers.

Sagent Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
)
PB ratio (
price to book ratio
)

Sagent Pharma Returns

ROE
(return on equity)

Sagent Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

SGNT Industry Peers

Company Price Change (%)
Flexion Therapeutics (FLXN)18.430.44 (2.33%)
Biocryst Pharma (BCRX)7.280.03 (0.41%)
Dr. Reddy's Laboratories (RDY)35.291.44 (3.92%)
Teligent (TLGT)3.820.05 (1.33%)
Merck (MRK)71.10.32 (0.45%)
Bristol-myers Squibb (BMY)62.250.5 (0.81%)
Abbvie (ABBV)92.260.42 (0.45%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Sagent Pharmaceuticals Inc Stock News - Partner Headlines

Sagent Pharma Financial Statements

income statement20152014201320122011
Net Sales or Revenues318.29M288.98M244.75M183.61M152.4M
Net Income-21.88M39.88M29.59M-16.81M-26.42M
Total Operating Expense132.25M67.1M46.13M46.59M40.43M
View Sagent Pharma income statement
balance sheet20152014201320122011
Total Assets349.73M381.48M310.2M172.31M230.5M
Total Liabilities98.63M105.73M74.18M40.46M88.83M
Shareholders Equity251.09M275.75M236.02M131.85M141.66M
View Sagent Pharma balance sheet
cash flow statement20152014201320122011
Net Increase (Decrease) in Assets Liabilities-18.83M-8.71M-18.67M-3.53M
Net Cash from (used by) Operating Activities-7.52M23.17M49.55M-20.12M-20.41M
Increase (Decrease) in Prop Plant And Equipment-6.71M-4.24M-1.1M-0.11M-0.32M
View Sagent Pharma cash flow statement

Sagent Pharma Stock Message Board

An investor needs to spend $21.76 to buy SGNT stock, as the closing Sagent Pharma stock price is $21.76. Sagent Pharma market capitalization is $716.12M and it represents the total market value of SGNT stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Sagent Pharma stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy SGNT stock than sell it, then Sagent Pharma stock price goes up. Conversely, if more investors wanted to sell SGNT stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 260,421 on the last trading day, as is evident from Sagent Pharma stock chart, and SGNT stock quote data. Sagent Pharma paid 0.00 stock dividends to its shareholders during last quarter. Sagent Pharma stock price history, gives the entire historical data for SGNT stock.